In rectal cancer, patients with high BRIP1 expression exhibited markedly longer overall survival compared with those with low expression (3324.42 ± 269.84 vs. 1305.64 ± 98.40 days; χ2 = 13.94; p < 0.001) (Figure 2A). Here, BRIP1 is linked to rectal cancer.